0001604950-14-000001.txt : 20140407 0001604950-14-000001.hdr.sgml : 20140407 20140407170019 ACCESSION NUMBER: 0001604950-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140407 DATE AS OF CHANGE: 20140407 EFFECTIVENESS DATE: 20140407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: scPharmaceuticals Inc. CENTRAL INDEX KEY: 0001604950 IRS NUMBER: 465184075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-215061 FILM NUMBER: 14749220 BUSINESS ADDRESS: STREET 1: 75 ARLINGTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-517-0730 MAIL ADDRESS: STREET 1: 75 ARLINGTON STREET STREET 2: SUITE 500 CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0707 D LIVE 0001604950 scPharmaceuticals Inc. 75 ARLINGTON STREET SUITE 500 BOSTON MA MASSACHUSETTS 02116 617-517-0730 DELAWARE None None Corporation true 2014 Pieter Muntendam 75 Arlington Street Suite 500 Boston MA MASSACHUSETTS 02116 Executive Officer Director Kush Parmar 75 Arlington Street Suite 500 Boston MA MASSACHUSETTS 02116 Director Mette Kirstine Agger 75 Arlington Street Suite 500 Boston MA MASSACHUSETTS 02116 Director Biotechnology Decline to Disclose 06b false 2014-03-24 false true false 0 17053016 9053016 8000000 false 9 0 0 0 false scPharmaceuticals Inc. /s/ Jeffrey Quillen Jeffrey Quillen Secretary 2014-04-07